NDC product
Chlorpromazine hydrochloride
NDC 16714-050 · Northstar Rx LLC
Key facts
| Product NDC | 16714-050 |
|---|---|
| Proprietary name | Chlorpromazine hydrochloride |
| Nonproprietary name | Chlorpromazine hydrochloride |
| Substances | CHLORPROMAZINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Northstar Rx LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA213368 |
| Pharmacologic classes | Phenothiazine [EPC], Phenothiazines [CS] |
| Marketing start | May 11, 2020 |
| Marketing end | Nov 30, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory